LAMF
LAMF

Punjab suspends six drugs, certain IV fluids after adverse reaction reports from hospitals

A communication in this regard was issued by the director of the health department and has been sent to all civil surgeons and medical superintendents in the state.
October 12, 2025 / 19:30 IST
Representative image

The Punjab health department has issued a directive ordering immediate discontinuation of six drugs and certain intravenous fluids following reports of suspected adverse drug reactions (ADRs) from various health facilities in the state, said officials on Sunday.

A communication in this regard was issued by the director of the health department and has been sent to all civil surgeons and medical superintendents in the state.

The IV fluids and drugs, which will not be used, include normal saline (sodium chloride injection IP 0.9 per cent), ciprofloxacin injection 200 mg, DNS 0.9 per cent, bupivacaine HCL with dextrose injection and N/S dextrose 5 per cent IV fluid.

It has come to the notice of this office that suspected cases of adverse drug reactions have been reported in certain facilities following the use of specific drugs and IV fluids, said the communication.

As a precautionary measure, the department has suspended the use of these items until further notice, emphasising patient safety as the top priority, said the officials.

PTI
first published: Oct 12, 2025 07:29 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347